159 related articles for article (PubMed ID: 19564101)
1. Radiochemotherapy for bladder cancer.
Ott OJ; Rödel C; Weiss C; Wittlinger M; St Krause F; Dunst J; Fietkau R; Sauer R
Clin Oncol (R Coll Radiol); 2009 Sep; 21(7):557-65. PubMed ID: 19564101
[TBL] [Abstract][Full Text] [Related]
2. Trimodality treatment and selective organ preservation for bladder cancer.
Rödel C; Weiss C; Sauer R
J Clin Oncol; 2006 Dec; 24(35):5536-44. PubMed ID: 17158539
[TBL] [Abstract][Full Text] [Related]
3. Current status of radiation therapy and combined-modality treatment for bladder cancer.
Rödel C
Strahlenther Onkol; 2004 Nov; 180(11):701-9. PubMed ID: 15549188
[TBL] [Abstract][Full Text] [Related]
4. An update of combined modality therapy for patients with muscle invading bladder cancer using selective bladder preservation or cystectomy.
Shipley WU; Kaufman DS; Heney NM; Althausen AF; Zietman AL
J Urol; 1999 Aug; 162(2):445-50; discussion 450-1. PubMed ID: 10411054
[TBL] [Abstract][Full Text] [Related]
5. Bladder preservation: optimizing radiotherapy and integrated treatment strategies.
Mak RH; Zietman AL; Heney NM; Kaufman DS; Shipley WU
BJU Int; 2008 Nov; 102(9 Pt B):1345-53. PubMed ID: 19035903
[TBL] [Abstract][Full Text] [Related]
6. Bladder preservation in selected patients with muscle-invasive bladder cancer by complete transurethral resection of the bladder plus systemic chemotherapy: long-term follow-up of a phase 2 nonrandomized comparative trial with radical cystectomy.
Solsona E; Climent MA; Iborra I; Collado A; Rubio J; Ricós JV; Casanova J; Calatrava A; Monrós JL
Eur Urol; 2009 Apr; 55(4):911-9. PubMed ID: 18722046
[TBL] [Abstract][Full Text] [Related]
7. Selective organ preservation in muscle-invasive bladder cancer: review of the literature.
Khosravi-Shahi P; Cabezón-Gutiérrez L
Surg Oncol; 2012 Mar; 21(1):e17-22. PubMed ID: 22088598
[TBL] [Abstract][Full Text] [Related]
8. Radiochemotherapy with cisplatin and 5-fluorouracil after transurethral surgery in patients with bladder cancer.
Weiss C; Engehausen DG; Krause FS; Papadopoulos T; Dunst J; Sauer R; Rödel C
Int J Radiat Oncol Biol Phys; 2007 Jul; 68(4):1072-80. PubMed ID: 17467193
[TBL] [Abstract][Full Text] [Related]
9. Bladder preserving strategies for muscle-invasive bladder cancer.
Merseburger AS; Matuschek I; Kuczyk MA
Curr Opin Urol; 2008 Sep; 18(5):513-8. PubMed ID: 18670277
[TBL] [Abstract][Full Text] [Related]
10. Induction cisplatin and fluorouracil-based chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer.
Lin CC; Hsu CH; Cheng JC; Huang CY; Tsai YC; Hsu FM; Huang KH; Cheng AL; Pu YS
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):442-8. PubMed ID: 19307067
[TBL] [Abstract][Full Text] [Related]
11. Conservative surgery, patient selection, and chemoradiation as organ-preserving treatment for muscle-invading bladder cancer.
Douglas RM; Kaufman DS; Zietman AL; Althausen AF; Heney NM; Shipley WU
Semin Oncol; 1996 Oct; 23(5):614-20. PubMed ID: 8893872
[TBL] [Abstract][Full Text] [Related]
12. Multimodality bladder preservation therapy for muscle-invasive bladder tumors.
Fernando SA; Sandler HM
Semin Oncol; 2007 Apr; 34(2):129-34. PubMed ID: 17382796
[TBL] [Abstract][Full Text] [Related]
13. The value of bladder-conserving strategies in muscle-invasive bladder carcinoma compared with radical surgery.
Merseburger AS; Kuczyk MA
Curr Opin Urol; 2007 Sep; 17(5):358-62. PubMed ID: 17762631
[TBL] [Abstract][Full Text] [Related]
14. Bladder-sparing therapy for muscle-infiltrating bladder cancer.
Pansadoro V; Emiliozzi P
Nat Clin Pract Urol; 2008 Jul; 5(7):368-75. PubMed ID: 18560383
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy for muscle-invasive bladder cancer treated with definitive radiotherapy: persisting uncertainties.
Choueiri TK; Raghavan D
Nat Clin Pract Oncol; 2008 Aug; 5(8):444-54. PubMed ID: 18577983
[TBL] [Abstract][Full Text] [Related]
16. Current status of radiation therapy for bladder cancer.
Sandler HM; Mirhadi AJ
Expert Rev Anticancer Ther; 2010 Jun; 10(6):895-901. PubMed ID: 20553213
[TBL] [Abstract][Full Text] [Related]
17. Organ preservation in the management of bladder and prostate cancer.
Vitale V
Rays; 1997; 22(3):406-9. PubMed ID: 9446944
[TBL] [Abstract][Full Text] [Related]
18. Total cystectomy versus bladder preservation therapy for locally invasive bladder cancer: effect of combined therapy using balloon-occluded arterial infusion of anticancer agent and hemodialysis with concurrent radiation.
Azuma H; Yamamoto K; Inamoto T; Ibuki N; Kotake Y; Sakamoto T; Kiyama S; Ubai T; Takahara K; Segawa N; Narumi Y; Katsuoka Y
Am J Clin Oncol; 2009 Dec; 32(6):592-606. PubMed ID: 19593084
[TBL] [Abstract][Full Text] [Related]
19. Benchmarks achieved in the delivery of radiation therapy for muscle-invasive bladder cancer.
Coen JJ; Zietman AL; Kaufman DS; Shipley WU
Urol Oncol; 2007; 25(1):76-84. PubMed ID: 17208144
[TBL] [Abstract][Full Text] [Related]
20. Bladder preservation therapy conducted by intra-arterial chemotherapy and radiotherapy for muscle invasive bladder cancer.
Hashine K; Kusuhara Y; Miura N; Shirato A; Sumiyoshi Y; Kataoka M
Jpn J Clin Oncol; 2009 Jun; 39(6):381-6. PubMed ID: 19351661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
